citric acid, anhydrous has been researched along with xanthine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burkitt, MJ; Gilbert, BC | 1 |
| Ashizawa, N; Matsumoto, K; Nagata, O; Nakazawa, T; Shimo, T | 1 |
| Ashizawa, N; Matsumoto, K; Moto, M; Nagata, O; Shimo, T; Taniguchi, T | 1 |
| Barri, T; Dragsted, LO | 1 |
| Ashizawa, N; Iwanaga, T; Matsumoto, K; Moto, M; Saito, K; Shimo, T | 1 |
5 other study(ies) available for citric acid, anhydrous and xanthine
| Article | Year |
|---|---|
Model studies of the iron-catalysed Haber-Weiss cycle and the ascorbate-driven Fenton reaction.
Topics: Ascorbic Acid; Citrates; Citric Acid; Edetic Acid; Electron Spin Resonance Spectroscopy; Ferric Compounds; Ferrous Compounds; Hydroxides; Hydroxyl Radical; Hydroxylation; Iron; Nitrilotriacetic Acid; Oxidation-Reduction; Pentetic Acid; Phytic Acid; Salicylates; Salicylic Acid; Succinates; Succinic Acid; Xanthine; Xanthine Oxidase; Xanthines | 1990 |
Simultaneous treatment with citrate prevents nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitor, in rats.
Topics: Animals; Citric Acid; Crystallization; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Kidney Diseases; Macaca fascicularis; Male; Nitriles; Pyridines; Rats; Rats, Sprague-Dawley; Xanthine; Xanthine Dehydrogenase; Xanthine Oxidase | 2005 |
Establishment of simultaneous treatment model with citrate for preventing nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitor, in rats.
Topics: Animals; Chelating Agents; Citric Acid; Disease Models, Animal; Enzyme Inhibitors; Kidney Diseases; Male; Nitriles; Pyridines; Rats; Rats, Inbred F344; Time Factors; Xanthine; Xanthine Dehydrogenase | 2011 |
UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant.
Topics: Anticoagulants; Artifacts; Chromatography, High Pressure Liquid; Citric Acid; Edetic Acid; Heparin; Humans; Hypoxanthine; Metabolomics; Multivariate Analysis; Plasma; Principal Component Analysis; Serum; Spectrometry, Mass, Electrospray Ionization; Xanthine | 2013 |
Xanthine crystals induced by topiroxostat, a xanthine oxidoreductase inhibitor, in rats, cause transitional cell tumors.
Topics: Administration, Oral; Animals; Calculi; Carcinoma, Transitional Cell; Cell Proliferation; Citric Acid; Crystallization; Enzyme Inhibitors; Female; Kidney Neoplasms; Male; Nitriles; Papilloma; Pyridines; Rats, Inbred F344; Risk Assessment; Risk Factors; Sex Factors; Species Specificity; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms; Xanthine; Xanthine Dehydrogenase | 2014 |